NightHawk Biosciences Profit Margin

NightHawk Biosciences (NHWK) currently reports a profit margin of -704.47% as of September 2025. That compares with -1128.75% in the prior-year period — up 37.6% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore NightHawk Biosciences's profit margin history and peer comparisons.

NightHawk Biosciences's profit margin increased from -1128.75% to -704.47% — a 37.6% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NightHawk Biosciences's profit margin of -704.47% is lower than the Healthcare sector average of 13.76%. That is roughly 5219.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but NightHawk Biosciences's current -704.47% should be judged against Healthcare norms (sector average: 13.76%) and against NHWK's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -704.47%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for NightHawk Biosciences, and consider following NHWK for alerts when major investors trade the stock.